Agios Pharmaceuticals (AGIO) Other Non Operating Income: 2021-2025
Historic Other Non Operating Income for Agios Pharmaceuticals (AGIO) over the last 4 years, with Sep 2025 value amounting to $67,000.
- Agios Pharmaceuticals' Other Non Operating Income fell 95.94% to $67,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 47.30%. This contributed to the annual value of $6.5 million for FY2024, which is 7.13% up from last year.
- According to the latest figures from Q3 2025, Agios Pharmaceuticals' Other Non Operating Income is $67,000, which was down 87.19% from $523,000 recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Other Non Operating Income registered a high of $4.6 million during Q3 2021, and its lowest value of $67,000 during Q3 2025.
- Its 3-year average for Other Non Operating Income is $1.3 million, with a median of $1.6 million in 2024.
- In the last 5 years, Agios Pharmaceuticals' Other Non Operating Income skyrocketed by 37.81% in 2024 and then crashed by 95.94% in 2025.
- Quarterly analysis of 5 years shows Agios Pharmaceuticals' Other Non Operating Income stood at $3.3 million in 2021, then plummeted by 58.48% to $1.4 million in 2022, then increased by 26.23% to $1.7 million in 2023, then fell by 5.25% to $1.6 million in 2024, then plummeted by 95.94% to $67,000 in 2025.
- Its Other Non Operating Income was $67,000 in Q3 2025, compared to $523,000 in Q2 2025 and $1.3 million in Q1 2025.